FCMI
JNCE

Foresite Capital Management II’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Foresite Capital Management II’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-119,912
Closed -$1.87M – 12
2017
Q3 		$1.87M Hold
119,912
– – 0.76% 8
2017
Q2 		$1.68M Hold
119,912
– – 0.77% 8
2017
Q1 		$2.64M Buy
+119,912
New +$2.64M 1.13% 8